secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nkarta, Inc. (NKTX)
CIK:        0001787400
Form:       8-K
Filed at:   2023-06-26T23:59:59+00:00
Accession:  0000950170-23-029860
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nkarta to host conference call to discuss updated NKX101 clinical data on June 27
--------------------------------------------------------------------------------

- Press release on June 26, 2023 announces conference call for June 27, 2023 at 8:00 a.m. ET.
- Call to review updated clinical data from ongoing trial of NKX101, an allogeneic CAR NK cell therapy targeting NKG2D ligands.
- Company ticker NKTX; slides will be available on Nkarta's website.
- Replay of call archived for approximately four weeks.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787400/000095017023029860/0000950170-23-029860-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787400/000095017023029860/nktx-20230626.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-029860

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer